Assays
What is an Assay?Filters
Antibody-dependent complement deposition measures complement protein binding following antibody interaction. The assay detects complement activation as an indicator of antibody-mediated immune function. Input: Antibody-coated target cells Output: Complement deposition measurement or fluorescence data file.
Submitter: Charles Demurjian
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: IMPAcTB
Antibody-dependent cellular phagocytosis measures immune cell uptake of antibody-coated targets. The assay quantifies phagocytic activity as an indicator of antibody function and cellular response. Input: Antibody-treated target cells and effector cells Output: Phagocytosis data file (e.g., fluorescence or imaging-based readouts).
Submitter: Charles Demurjian
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: IMPAcTB
Antibody-dependent neutrophil phagocytosis evaluates antibody-mediated uptake of targets by neutrophils. It measures fluorescence or imaging-based signals to assess innate immune activity. Input: Antibody-labeled target cells and neutrophils Output: Phagocytosis data file indicating neutrophil uptake efficiency.
Submitter: Charles Demurjian
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: IMPAcTB
A bacterial challenge assay exposes biological samples or model organisms to a defined bacterial strain. It is used to study infection dynamics, host-pathogen interactions, or immune response under controlled conditions. Input: Biological system or culture Output: Treated sample or response dataset reflecting bacterial exposure effects.
Submitter: Charles Demurjian
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: IMPAcTB
Submitter: Charles Demurjian
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: IMPAcTB